Xenon Pharmaceuticals (XENE) Misses Q2 EPS by 5c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Active options: META SMCI MU SOFI GOOG NOK MSTR AVGO AMD HOOD
• Increasing unusual put option volume: OSS CTSH PZZA BFLY CDNS WMB KD DFTX CAN HIVE SOC WYFI SIMO